MAIA-Ovarian Adaptive Platform Clinical Trial to Evaluate Safety and Efficacy of COM701 maintenance treatment in Relapsed Platinum Sensitive Ovarian Cancer (PSOC)

Compugen Ltd (CGEN)

We couldn't retrieve the full text for this release. Read it on the company's site.